BROOKE VAN VELDEN (Deputy Leader—ACT): Thank you, Madam Chair. I wanted to go back to a topic that my colleague Andrew Bayly was talking about with the Minister, before, about the supply correction information under new section 19N, inserted by clause 19, and I note that the section applies "where a registered person has previously issued taxable supply information that includes an inaccuracy." But there is a subclause (4), which states that "a registered person is not required to supply correction information under subsection (2) for a supply because part of the consideration shown in the taxable supply information for the supply has been rebated under a Pharmac agreement to Pharmac, whether Pharmac is acting on its own account or as an agent for a public authority." And I just wondered if the Minister would be able to provide some clarity around this sub-clause about the benefit of it being added, what the hope was behind it, and why Pharmac itself has been singled out with its own subclause, because I know there will be a lot of people who have interest in medicines access. But I've tried to look around the report that came back from the Finance and Expenditure Committee, and I noted in that report there was no reference to Pharmac. So I wondered if the Minister could provide a little clarity about its addition into this new section 19N.